Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
GIFTS
Enrolling by invitation
1,360 enrolled
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting
2,000 enrolled
INTERCEPTioN
Recruiting
350 enrolled
GENTleMEN
Terminated
799 enrolled
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Terminated
199 enrolled 8 charts
Prostasomes as Diagnostic Tool for Prostate Cancer Detection
Suspended
600 enrolled
TSC Biosample Repository and Natural History Database
Recruiting
5,000 enrolled
Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
Completed
1,488 enrolled
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
Active not recruiting
825 enrolled
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Completed
88 enrolled
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Active not recruiting
600 enrolled
Health-promoting Lifestyle in a Genetic Counseling Clinic
Completed
140 enrolled
MediSein
Terminated
460 enrolled
Personalized Sequence for Thoracic, Esophageal, and H&N Cancer
Unknown
200 enrolled
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Unknown
200 enrolled
Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
Unknown
60 enrolled
Systemic Screening for Hereditary Colorectal Cancer in China
Unknown
500 enrolled
HARBOR
Unknown
628 enrolled
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Withdrawn